Why the study?
Does massive weight loss improve arterial oxygenation and pulmonary function tests in morbidly obese patients?
Does massive weight loss improve arterial oxygenation and pulmonary function tests in morbidly obese patients?
Massive weight loss in morbidly obese patients significantly improves expiratory reserve volume, which correlates directly with improvements in arterial oxygenation.
May support weight loss for oxygenation gains in morbid obesity; hypothesis-generating for ERV role, needs RCTs.
Pulmonary function tests (PFTs) and arterial oxygenation were studied 24 hours preoperatively and again at varying times (5 to 20 months) during the postoperative weight loss of 37 morbidly obese patients. Among PFTs, expiratory reserve volume (ERV) demonstrated the most significant (P less than 0.001) improvement with weight loss. No clinically relevant differences were found after weight loss in FEV1, FVC, or MMEF. In 11 patients whose arterial blood gases were sampled before and after weight loss, a significant correlation was demonstrated between change in ERV and change in Pao2 (r = 0.59, P less than 0.05) and P(A-a)o2 (r = 0.76, P less than 0.01). When weight loss is expressed as either change in body mass index (delta BMI) or as a change in percent of ideal weight (delta wt), there existed a weight loss threshold for improvement in arterial oxygenation. A delta BMI of greater than 20 or a delta wt more than 100 per cent resulted in a significant improvement in Pao2 (P less than 0.01) or P(A-a)o2 (P less than 0.05). These data suggest that morbidly obese patients do not meaningfully improve FEV1, FVC, or MMEF with massive weight loss. However, there is a significant improvement in ERV that directly correlates with improvement in both Pao2, and P(A-a)o2.
No takes yet. Share an insight, caveat, or question.
Vaughan et al. (1981) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: